PHSCN, A POTENT SYSTEMIC THERAPY FOR HUMAN BREAST CANCER THAT TARGETS ALPHA5 BETA1 INTEGRIN TO PREVENT METASTATIC INVASION
$583,125FY2011Department of DefenseDOD
Regents Of The University Of Michigan
Investigators
View source on USAspending →PHSCN, A POTENT SYSTEMIC THERAPY FOR HUMAN BREAST CANCER THAT TARGETS ALPHA5 BETA1 INTEGRIN TO PREVENT METASTATIC INVASION · GrantIndex